PH12021550299A1 - A gabaa receptor ligand - Google Patents

A gabaa receptor ligand

Info

Publication number
PH12021550299A1
PH12021550299A1 PH12021550299A PH12021550299A PH12021550299A1 PH 12021550299 A1 PH12021550299 A1 PH 12021550299A1 PH 12021550299 A PH12021550299 A PH 12021550299A PH 12021550299 A PH12021550299 A PH 12021550299A PH 12021550299 A1 PH12021550299 A1 PH 12021550299A1
Authority
PH
Philippines
Prior art keywords
receptor ligand
gabaa receptor
useful
pain
dimethoxypyrimidin
Prior art date
Application number
PH12021550299A
Other languages
English (en)
Inventor
Janus S Larsen
Dipak Amrutkar
Thomas Amos Jacobsen
Tino Dyhring
Karin Sandager Nielsen
Original Assignee
Saniona As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Saniona As filed Critical Saniona As
Publication of PH12021550299A1 publication Critical patent/PH12021550299A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PH12021550299A 2018-09-13 2021-02-10 A gabaa receptor ligand PH12021550299A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18194297 2018-09-13
PCT/EP2019/074465 WO2020053377A1 (en) 2018-09-13 2019-09-13 A gabaa receptor ligand

Publications (1)

Publication Number Publication Date
PH12021550299A1 true PH12021550299A1 (en) 2021-10-25

Family

ID=63579205

Family Applications (1)

Application Number Title Priority Date Filing Date
PH12021550299A PH12021550299A1 (en) 2018-09-13 2021-02-10 A gabaa receptor ligand

Country Status (24)

Country Link
US (1) US11396510B2 (cg-RX-API-DMAC7.html)
EP (1) EP3849976B1 (cg-RX-API-DMAC7.html)
JP (1) JP7353663B2 (cg-RX-API-DMAC7.html)
KR (1) KR102712565B1 (cg-RX-API-DMAC7.html)
CN (1) CN112714765B (cg-RX-API-DMAC7.html)
AU (1) AU2019338236B2 (cg-RX-API-DMAC7.html)
BR (1) BR112021004661A2 (cg-RX-API-DMAC7.html)
CA (1) CA3110283A1 (cg-RX-API-DMAC7.html)
DK (1) DK3849976T3 (cg-RX-API-DMAC7.html)
EA (1) EA202190717A1 (cg-RX-API-DMAC7.html)
ES (1) ES2935705T3 (cg-RX-API-DMAC7.html)
FI (1) FI3849976T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20230067T1 (cg-RX-API-DMAC7.html)
HU (1) HUE060943T2 (cg-RX-API-DMAC7.html)
IL (1) IL281335B2 (cg-RX-API-DMAC7.html)
LT (1) LT3849976T (cg-RX-API-DMAC7.html)
MX (1) MX2021003010A (cg-RX-API-DMAC7.html)
PH (1) PH12021550299A1 (cg-RX-API-DMAC7.html)
PL (1) PL3849976T3 (cg-RX-API-DMAC7.html)
PT (1) PT3849976T (cg-RX-API-DMAC7.html)
SG (1) SG11202101360VA (cg-RX-API-DMAC7.html)
SI (1) SI3849976T1 (cg-RX-API-DMAC7.html)
WO (1) WO2020053377A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA202100976B (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20240197733A1 (en) 2021-04-16 2024-06-20 Saniona A/S A gaba receptor modulator for use in the treatment of pain
EP4777104A1 (en) * 2023-09-15 2026-07-22 Saniona A/S A gaba receptor modulator for treating disorders associated with sleep spindle deficits
EP4777103A1 (en) * 2023-09-15 2026-07-22 Saniona A/S A gaba receptor modulator for use in the treatment of absence seizures
WO2026109691A1 (en) * 2024-11-22 2026-05-28 Saniona A/S A gaba receptor modulator for use in the treatment of tremor

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU675484B2 (en) 1993-03-24 1997-02-06 Neurosearch A/S Benzimidazole compounds, their use and preparation
GB9702524D0 (en) 1997-02-07 1997-03-26 Merck Sharp & Dohme Therapeutic agents
GB9813576D0 (en) * 1998-06-24 1998-08-19 Merck Sharp & Dohme Therapeutic agents
JP2002535407A (ja) * 1999-01-27 2002-10-22 メルク シャープ エンド ドーム リミテッド Gaba受容体のリガンドとしてのトリアゾロピリダジン誘導体
GB9921150D0 (en) 1999-09-07 1999-11-10 Merck Sharp & Dohme Therapeutic agents
GB0208394D0 (en) * 2002-04-11 2002-05-22 Merck Sharp & Dohme Therapeutic agents
GB0208392D0 (en) * 2002-04-11 2002-05-22 Merck Sharp & Dohme Therapeutic compounds
GB0212048D0 (en) 2002-05-24 2002-07-03 Merck Sharp & Dohme Therapeutic agents
MXPA05010449A (es) 2003-04-03 2006-05-31 Neurosearch As Derivados del bencimidazol y su uso para modular el complejo del receptor de gabaa.
TWI391381B (zh) * 2006-03-24 2013-04-01 Neurosearch As 新穎的苯并咪唑衍生物、含有其之醫藥組成物、及其於製造藥物之用途
TW201029986A (en) 2008-11-14 2010-08-16 Neurosearch As Novel compounds
BR112018015386A2 (pt) 2016-01-27 2019-03-19 Universität Zürich uso de moduladores de receptor gabaa para tratamento de prurido

Also Published As

Publication number Publication date
LT3849976T (lt) 2023-02-10
EP3849976A1 (en) 2021-07-21
PT3849976T (pt) 2023-01-13
US11396510B2 (en) 2022-07-26
HUE060943T2 (hu) 2023-04-28
EA202190717A1 (ru) 2021-09-22
DK3849976T3 (da) 2023-01-23
FI3849976T3 (fi) 2023-02-19
WO2020053377A1 (en) 2020-03-19
CA3110283A1 (en) 2020-03-19
PL3849976T3 (pl) 2023-02-27
IL281335A (en) 2021-04-29
CN112714765A (zh) 2021-04-27
MX2021003010A (es) 2021-05-27
BR112021004661A2 (pt) 2021-06-01
KR102712565B1 (ko) 2024-10-02
CN112714765B (zh) 2023-06-30
SG11202101360VA (en) 2021-03-30
IL281335B1 (en) 2024-03-01
ZA202100976B (en) 2022-08-31
JP2022500445A (ja) 2022-01-04
US20210332042A1 (en) 2021-10-28
HRP20230067T1 (hr) 2023-03-17
ES2935705T3 (es) 2023-03-09
IL281335B2 (en) 2024-07-01
AU2019338236B2 (en) 2025-01-09
SI3849976T1 (sl) 2023-03-31
JP7353663B2 (ja) 2023-10-02
EP3849976B1 (en) 2022-10-26
KR20210061338A (ko) 2021-05-27
AU2019338236A1 (en) 2021-05-20

Similar Documents

Publication Publication Date Title
BR112019007806A2 (pt) composição bucal de múltiplas fases para a liberação de agentes ativos para tratamento bucal
DK3805233T3 (da) (r)- og (s)-enantiomerer af n-(5-(3-hydroxypyrrolidin-1-yl)-2-morpholinoxazolo[4,5-b]pyridin-6-yl)-2-(2-methylpyridin-4-yl)oxazol-carboxamid som irak4-hæmmere til cancerbehandling
EA202190717A1 (ru) Лиганд рецептора гамк-а
CR20200089A (es) Compuestos espirocíclicos y sus métodos de preparación y uso
PH12016502479A1 (en) Formulated receptor polypeptides and related methods
JOP20200022A1 (ar) مركبات حلقية لولبية وطرق تصنيعها واستخدامها
PH12019502646A1 (en) Pyrazole magl inhibitors
MY190137A (en) Noxious organism control agent composition for agricultural and horticultural applications, and method for using said composition
PH12019501079A1 (en) Magl inhibitors
EP3760625C0 (en) BICYCLIC LACTAMS AS PROTEIN KINASE 1 (RIP1) INHIBITORS INTERACTING WITH RECEPTORS FOR TREATMENT E.G. OF INFLAMMATORY DISEASES
MX2019003980A (es) 1h-imidazo[4,5-b]piridin-2(3h)-onas sustituidas y su uso como moduladores del receptor glun2b.
CL2019001381A1 (es) Método para el tratamiento de glomeruloesclerosis segmentaria focal.
MX2020008265A (es) Derivados farmaceuticos del anillo heterobiciclico 6,5.
DK3624796T3 (da) Pyrrolopyridin.anilinforbindelser til behandling af hudlidelse
EP4599830A3 (en) Isoxazoline compounds for use in treating demodicosis
MX2016015762A (es) Derivados de alquilo y arilo de compuestos de 1-oxa-4,9-diazaspiro undecano que tienen actividad multimodal contra el dolor.
EA201891311A1 (ru) Система для возможного динамического позиционирования лыжного крепления на лыже
EP3497914A4 (en) LAST ARRIVAL PROCESSING, FIRST SERVED OF COMMUNICATION SESSION REQUESTS
EP4268897A3 (en) Minocycline compounds for biodefense
EP3851099C0 (en) COMPOSITION INTENDED FOR THE TREATMENT OF FIBROTIC DISEASES, COMPRISING BENZHYDRYL THIOACETAMIDE AS THE ACTIVE INGREDIENT
MX2017006709A (es) Agente para prevenir o mejorar sintomas causados por desequilibrio de las hormonas sexuales.
EA201990645A1 (ru) Пиридо пятичленное ароматическое циклическое соединение, способ его получения и применение
BR112018071586A2 (pt) uso de beta-agonistas da tireoide
EA201890412A1 (ru) АНТИБАКТЕРИАЛЬНЫЕ АГЕНТЫ, СОДЕРЖАЩИЕ ПИРАЗИНО[2,3-b][1,4]ОКСАЗИН-3-ОН ИЛИ РОДСТВЕННУЮ КОЛЬЦЕВУЮ СИСТЕМУ
AU2015295120A8 (en) [1,2,4]triazolo[4,3-b]pyridazines for use in the treatment of proliferative diseases